.Pharmacolibrary.Drugs.V_Various.V08A_XRayContrastMediaIodinated.V08AB02_Iohexol.Iohexol .Pharmacolibrary.Drugs.V_Various.V08A_XRayContrastMediaIodinated.V08AB02_Iohexol.Iohexol| name: | Iohexol |
| ATC code: | V08AB02 | route: | intravenous |
| n-compartments | 2 |
Iohexol is a non-ionic, water-soluble radiographic contrast agent commonly used in diagnostic imaging procedures such as computed tomography (CT) and angiography. It is typically administered intravenously and aids in the visualization of blood vessels and tissues. Iohexol is approved and widely used in clinical practice.
Pharmacokinetics in healthy adult volunteers after a single intravenous bolus injection; reported in a two-compartment model.
Baklouti, S, et al., & Cagnardi, P (2021). Population Pharmacokinetic Model of Iohexol in Dogs to Estimate Glomerular Filtration Rate and Optimize Sampling Time. Frontiers in pharmacology 12 634404–None. DOI:10.3389/fphar.2021.634404 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33995036
Djerada, Z, et al., & Malinovsky, JM (2014). Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response. British journal of clinical pharmacology 77(6) 1027–1038. DOI:10.1111/bcp.12291 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24252055
Carrier, P, et al., & Loustaud-Ratti, V (2022). Iohexol plasma and urinary concentrations in cirrhotic patients: A pilot study. World journal of hepatology 14(8) 1621–1632. DOI:10.4254/wjh.v14.i8.1621 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36157874